REMEGEN (09995) is recommended to adopt the A-share stock incentive plan in 2023.

19/11/2023

GMT Eight

REMEGEN (09995) announced that the board of directors recommends adopting the 2023 A-share stock incentive plan, planning to grant approximately 1.7831 million restricted stocks to the incentive beneficiaries. Upon the initial grant, 1.43245 million restricted stocks will be allocated, and approximately 0.3506 million restricted stocks will be reserved. The grant price (including reserved grants) is set at RMB 49.77 per A-share.

YUM CHINA (09987) repurchased approximately 249,200 shares on November 17th, costing approximately $11.5 million.

REMEGEN (09995) plans to grant 1,783,100 restricted shares based on the proposed A-share restricted stock incentive plan for 2023.

Contact: contact@gmteight.com

REMEGEN (09995) is recommended to adopt the A-share stock incentive plan in 2023.

RECOMMEND

Caitong: Scaling Law suggests focusing on the AI foundation during the training and inference transfer phases.

GAUSH MEDITECH (02407): The stock price has dropped by 80% from its peak, and funds from the Hong Kong Stock Connect have chosen to exit before the "outbound connect" is implemented.

Tonight's Buffett shareholder letter! In addition to the record cash reserve, there are also three things that are receiving a lot of attention.